Dallas-based sales representative Jennifer Mansion claims Eli Lilly fired her after she objected to the company promoting its diabetes medication, Mounjaro, for unapproved weight-loss uses. Her federal complaint details that colleagues marketed the therapy for obesity prior to receiving official regulatory approval for that specific indication. Mansion also witnessed a physician pitching the medication for weight management during a promotional luncheon sponsored by the drugmaker.
Key points
Pharmaceutical manufacturers are legally barred from marketing prescription medications f…: Pharmaceutical manufacturers are legally barred from marketing prescription medications for unapproved indications without federal regulatory clearance.
Physicians may legally prescribe approved drugs off-label, but commercial manufacturers c…: Physicians may legally prescribe approved drugs off-label, but commercial manufacturers cannot actively market those off-label uses.
The lawsuit claims internal employee objections to improper drug promotion led directly t…: The lawsuit claims internal employee objections to improper drug promotion led directly to retaliatory termination.
Sources checked by our analysis pipeline: 1
A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining the company was promoting its Mounjaro diabetes drug to combat weight loss before receiving regulatory approval to do so.
Jennifer Mansion, who was hired as a senior territory manager in Dallas four years ago, claimed that she observed other Lilly sales reps promoting the diabetes drug as a salve for obesity. Mansion also contended that a physician touted Mounjaro as a weight-loss option during a luncheon sponsored by the drugmaker, according to the suit filed in federal court in Texas.
Such promotions are known as off-label marketing in the pharmaceutical industry. The phrase refers to promoting a medicine for a usage that was not approved by the U.S. Food and Drug Administration. A physician may prescribe a medicine for an unapproved use, but a drugmaker is not permitted to market its drug for that purpose.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
A joint investigation by ITV News and the Guardian has revealed allegations from multiple women who claim the prominent entertainer exploited his celebrity status to groom and assault them as teenagers. The findings have triggered immediate fallout across the British entertainment industry, resulting in programming removals and terminated professional representation. While the 55-year-old strongly denies committing any crimes, the claims threaten to permanently dismantle his career as both a television star and be…
A joint investigation by The Guardian and ITV News revealed multiple allegations from women who claim the prominent entertainer engaged in criminal misconduct, including the alleged sexual assault of a 15-year-old girl in 2007. The revelations emerged after a UK High Court judge denied his request for an injunction to conceal his identity from public reporting. The broadcaster BBC is already pulling his content and initiating a broad review of his work across all its platforms.
Paul McGann, an off-duty police officer working as a hospital security guard, was injured when fleeing theft suspects struck him with a vehicle outside an Indianapolis emergency department. The appellate decision allows his negligence lawsuit to move forward, focusing on claims that the medical facility failed to protect pedestrians through physical lot safety measures. This ruling rejects the hospital's earlier procedural defense that it had no duty to control third-party criminal actions.